Aarkstore - Moderate Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - PowerPoint PPT Presentation

Loading...

PPT – Aarkstore - Moderate Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 PowerPoint presentation | free to download - id: 71f8c2-MGEzN



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

Aarkstore - Moderate Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Description:

Moderate Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Moderate Pain. Browse full report @ – PowerPoint PPT presentation

Number of Views:12

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Aarkstore - Moderate Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015


1
Aarkstore - Moderate Pain-Global API
Manufacturers, Marketed and Phase III Drugs
Landscape, 2015
Category Pharmaceuticals and Healthcare
2
Moderate Pain-Global API Manufacturers, Marketed
and Phase III Drugs Landscape, 2015, Report
provides comprehensive insights about phase III
pipeline drugs and marketed drugs across the
Moderate Pain. A key objective of DelveInsights
report is to establish the understanding for API
Manufacturers for marketed and Phase III Pipeline
drugs across the different countries and regions
for the drugs falling under Moderate Pain. The
Report gives insights into patents providing the
patent protection data and marketing exclusivity
of all the drugs across the Moderate Pain. While
the leading brands, companies and chemicals are
considered thoroughly, DelveInsights report also
provides details on the Global API Manufacturers
across the globe covering Drug Master Filings of
US, Europe and API Manufacturers in Asia
specifically China and India. The research
analysis also presents the global sales forecasts
data till 2016.
Browse Complete Report http//www.aarkstore.com
/pharmaceuticals-healthcare/97799/moderate-pain-gl
obal-api-manufacturers-marketed-and-phase-iii-drug
s-landscape-2015
3
Data Sources
  • The report is built using data and information
    sourced from proprietary databases, primary and
    secondary research and in-house analysis by
    DelveInsight team of industry experts.
  • Secondary sources information and data has been
    collected from various printable and
    non-printable sources like search engines, News
    websites, Government Websites, Trade Journals,
    White papers, Magazines, Trade associations,
    Books, Industry Portals, Industry Associations
    and access to available databases.
  • Please noteThis report requires certain updates.
    We have all the information available but require
    3 business days to complete the process and
    ensure it is as up-to-date as possible. Certain
    sections in the report may be removed or altered
    based on the availability and relevance of data
    for the indicated disease.
  • .

4
Scope
  • A snapshot of the global Market therapeutics
    scenario for Moderate Pain.
  • A review of the marketed products under
    prescription for Moderate Pain, regulatory
    information and marketing status.
  • Coverage of global patent coverage and detailed
    commentaries on the US patent challenges.
  • Graphical representation of investigational
    products for patent expiry and market
    exclusivities across the globe.
  • Product profiles for marketed products for
    Moderate Pain with complete description of
    mechanism of action, therapeutic class, target,
    route(s) of administration and chemical details.
  • Coverage of API Manufacturers for Moderate Pain
    drugs in the United States, Europe and Asian
    Regions with location details.
  • Coverage of Regulatory filings in theUS, Europe,
    and Asia specifically India and China for
    Moderate Pain drugs.
  • Coverage of Route of Synthesis of Active
    Pharmaceutical Ingredient associated with
    Moderate Pain drugs.

5
Reasons to buy
  • Evaluate the marketing status and exclusivity
    details of Moderate Pain key products to exploit
    opportunities for generic drug development
    opportunities.
  • Identify and understand important and diverse
    types of therapeutics under Phase III development
    for Moderate Pain.
  • Design effective counter-strategies to gain
    competitive advantage by identifying the key
    patent expiry details and exclusivity with
    respect to Moderate Pain.
  • API intelligence over marketed drugs for Moderate
    Pain and gaining primary intelligence over active
    ingredients manufacturers across the globe.
  • API intelligence over leading Phase III Pipeline
    drugs.
  • Develop and design strategies by identifying the
    API manufacturers for Phase III Pipeline products
    to enhance and expand business potential and
    scope.

6
Table of Content
  • Indication Overview
  • Marketed Drugs
  • Marketed Details of Drugs by Application Type
  • Marketed Details of Drugs (NDA) by Marketing
    Status
  • Marketed Details of Drugs by Patent Expiration
    Timeline
  • Active Pharmaceutical Ingredient (API)
    Manufacturers Assessment
  • API Manufacturers by United States Drug Master
    File (US DMF) Status
  • API Manufacturers by US DMF Status (Drug
    Specific)
  • API Manufacturers in Europe by Country
  • API Manufacturers in India by State
  • API Manufacturers in China by Province
  • Marketed Details of Approved Drugs by Geography
  • Active Pharmaceutical Ingredient (API)
    Manufacturers Assessment for Phase III Pipeline
    Drugs

7
List of Tables
  • Moderate Pain Therapeutic Market, US, Marketed
    Drugs by Application Type, 2015
  • Moderate Pain Therapeutic Market, US, Marketed
    Drugs by Marketing Status, 2015
  • Moderate Pain Therapeutic Market, US, (Year),
    2015
  • Moderate Pain Marketed Drugs, API Manufacturers
    by US DMF Status, 2015
  • Moderate Pain Marketed Drugs, US DMF Status Drug
    Specific (Number), 2015
  • Moderate Pain Drugs, API Manufacturers, Europe by
    Country, 2015
  • Moderate Pain Drugs, API Manufacturers, India by
    State, 2015
  • Moderate Pain Drugs, API Manufacturers, China by
    Province, 2015
  • Moderate Pain Drugs, API Manufacturers by
    Geography 2015
  • Moderate Pain Phase III Pipeline Drugs, US DMF
    Status Drug Specific (Number), 2015
  • Moderate Pain Therapeutic Market, Global Sales
    2012-2016 (in million USD)
  • API Manufacturers for Drug, 2015
  •  
  •  

8
List of Figures
  • Moderate Pain Therapeutic Market, US, Marketed
    Drugs by Application Type (), 2015
  • Moderate Pain Therapeutic Market, US, Marketed
    Drugs by Marketing Status (), 2015
  • Moderate Pain Therapeutic Market, US, (Year),
    2015
  • Moderate Pain Marketed Drugs, API Manufacturers
    by US DMF Status (), 2015
  • Moderate Pain Marketed Drugs, US DMF Status Drug
    Specific (Number), 2015
  • Moderate Pain Drugs, API Manufacturers, Europe by
    Country, 2015
  • Moderate Pain Drugs, API Manufacturers, India by
    State, 2015
  • Moderate Pain Drugs, API Manufacturers, China by
    Province, 2015
  • Moderate Pain Drugs, API Manufacturers by
    Geography 2015

9
Related reports
  •  
  • Global Crohns Disease (CD) Market 2015-2019
  • Global Chronic Kidney Disease (CKD) Drugs Market
    2015-2019
  • Global Acquired Orphan Blood Diseases
    Therapeutics Market 2015-2019
  • Womens Health - Assessing the Need for a
    Targeted and Specialized Approach
  • Global Travel Vaccines Market 2015-2019
  • Global Acquired Orphan Blood Diseases
    Therapeutics Market 2015-2019
  • Patient Monitoring and Diagnostic Systems Markets
    in China
  • Hearing Aids Markets in China
  • Medical Imaging System and Equipment Markets in
    China 
  • Medical Devices Markets in China

10
  • Moderate Pain-Global API Manufacturers, Marketed
    and Phase III Drugs Landscape, 2015
  • Published Feb 2015 100 Pages
  • Moderate Pain-Global API Manufacturers, Marketed
    and Phase III Drugs Landscape, 2015, Report
    provides comprehensive insights about phase III
    pipeline drugs and marketed drugs across the
    Moderate Pain.
  • Price

Format Price
PDF 2000
Site License 4000
Enterprise Wide License 6000
11
Contact Us
Office Office No. - 809, 8th Floor,B-Wing,
Mahaavir Icon, Plot No.- 89 90,
Sector-15,CBD-Belapur, Navi Mumbai
400614, Maharashtra, India. Telefax No 91 22
4127 6660 24/7 Online Support 91
9987295242 General Inquiries 91 - 22 2756 4953
  • You Can Visit http//www.aarkstore.com
  • OR Mail us at contact_at_aarkstore.com
  • Blog
  • http//www.aarkstore.com/blog/
  • Conference
  • http//conference.aarkstore.com/
  • News
  • http//www.aarkstore.com/news
About PowerShow.com